Loading...
(Immuno)proteasomes as therapeutic target in acute leukemia
The clinical efficacy of proteasome inhibitors in the treatment of multiple myeloma has encouraged application of proteasome inhibitor containing therapeutic interventions in (pediatric) acute leukemia. Here, we summarize the positioning of bortezomib, as first-generation proteasome inhibitor, and s...
Na minha lista:
| Udgivet i: | Cancer Metastasis Rev |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721123/ https://ncbi.nlm.nih.gov/pubmed/29071527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-017-9699-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|